Suplemento
Melhor tecnologia, clínicas mais rápidas e tratamentos personalizados
12 junho 2020
· 20 MIN LEITURA
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original.image_file.100.100.file/royce-chen.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original.image_file.360.360.file/royce-chen.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/royce-chen.jpg/_jcr_content/renditions/original./royce-chen.jpg"})
Autor
Royce W.S. Chen, MD
Irving Medical Center, Columbia University, EUA
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.100.100.file/jesse-jung.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.360.360.file/jesse-jung.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.768.768.file/jesse-jung.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/jesse-jung.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original.image_file.1280.1280.file/jesse-jung.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original./jesse-jung.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/jesse-jung.jpg/_jcr_content/renditions/original./jesse-jung.jpg"})
Autor
Jesse J. Jung, MD
Especialista em vítreo e retina, East Bay Retina Consultants, Inc., EUA
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.100.100.file/sunil-shrivastava.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.360.360.file/sunil-shrivastava.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.768.768.file/sunil-shrivastava.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/sunil-shrivastava.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original./sunil-shrivastava.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original./sunil-shrivastava.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/272-improved-technologies/sunil-shrivastava.jpg/_jcr_content/renditions/original./sunil-shrivastava.jpg"})
Autor
Sunil K. Srivastava, MD
Especialista em retina, Cleveland Clinic, EUA
RESUMO
Como é que as novas e melhores tecnologias contribuem para clínicas mais rápidas e tratamentos personalizados?
Neste suplemento, originalmente publicado na Retina Today, um painel de especialistas analisa duas ferramentas de imagiologia, a angiografia por OCT e a imagiologia de fundo de olho com campo de visão ultra-amplo, com o objetivo de melhorar o diagnóstico e tratamento de doenças.